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If I have seen farther than others, it is because 
I was standing on the shoulders of giants. 
---- Isaac Newton 
 
If I have not seen as far as others, it is because 
giants were standing on my shoulders. 
---- Hal Abelson 
 
Reflections 
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At my current age of 73, the ability to see – some-
where into the mid-distance between the quotations 
above – has been shaped by mentors, colleagues, stu-
dents and trainees, friends and family. I started to write 
this since the second week of the CoVID-19-related lock-
down. Virtually nobody was seen outside, a bizarre ex-
perience that reminds me of my first memories as an 
infant in post-war occupied Vienna when people tried to 
avoid public encounters, particularly with patrolling 
Soviet soldiers. In mid-March 2020, nobody could fore-
see how the SARS-CoV2 pandemic would evolve. As my 
wife, an active hospital nurse, and our 12-year-old 
daughter at school had and have some risk to get infect-
ed, we agreed to temporarily separate. Now I stay in 
self-imposed isolation with our dog Gorry in a small 
rented apartment in the beautiful Vienna Woods. Like 
others who, during the present lockdown, have a chance 
to re-consider their way of life, I have ample time to 
reflect on my life and on neuropathology. I write this just 
based on my memories, as most of my written docu-
ments are either back in my home or have been de-
stroyed after I retired from my directorship of the (Clini-
cal) Institute of Neurology, formerly Neurological Insti-
tute (NI, Obersteiner Institute) in Vienna. Without 
doubt, the reader will detect in these memoirs the char-
acteristic reminiscence bump of psychology, i. e. the 
strongest memories date back to adolescence and early 
adulthood, and emotionally positive memories domi-
nate. However, I consider my whole professional life as 
extraordinary privilege to have done what I enjoyed 
most, having made many friends and met great person-
alities including true giants in medicine, science and 
research. Moreover, I believe to have witnessed the 
golden era of neuropathology, spanning from rather 
subjective interpretation of classical morphology to 
unprecedentedly detailed molecular diagnoses and fas-
cinating understanding of aetiologies and pathogenesis 
of diseases of the nervous system. I will keep this fasci-
nation forever. 
The first family 
My family had the almost obligatory migrant back-
ground of Viennese. Probably my later commitment for 
refugees and human rights was the subconscious recog-
nition of that fact. My father’s Budka (meaning small hut 
or kiosk in Slavic languages) family originated from the 
double town of Cieszyn (in Polish) / Těšín (in Czech) or 
Teschen (in German), at the Polish-Czech border in Sile-
sia, then part of the Austrian empire. My grandfather 
migrated to Vienna where my father was born. I have 
only faint memories of my grandfather – the most vivid 
one is an old photograph depicting him, with a huge 
moustache and in a typical knee-long body jersey next to 
a huge and heavy iron bike, as winner of an Austrian 
bicycling championship. Another memory is my first visit 
with him to the Prater entertainment park that had just 
re-opened. In a haunted house train taking us around 
many horrifying corners that I passed by firmly closing 
my eyes, a ghost took grandpa’s hat away. Grandpa 
became very angry and tried to hit the culprit ghost with 
his stick. I was greatly impressed by such courage – even 
against ghosts! – also resulting in getting the hat back at 
the entrance. My mother’s Panoš family had lived in 
Olomouc (in Czech) or Olmütz (in German) where she 
was born. Her father was a recognised expert of beer 
brewing, then as now a classical Czech talent, who be-
came employed by the then well-known Nussdorf brew-
ery in Vienna. My fondness for beer seems to be another 
subconscious recognition of my heritage. 
I was born in 1946 in a small village in Upper Aus-
tria where my parents had to relocate after WWII bombs 
had destroyed their home in Vienna. However, we re-
turned to Vienna when I was 3, and rented an apartment 
in an area where most buildings had been either razed 
to the ground or heavily damaged. For a boy, this was 
paradise: the building debris of ruins just across the 
street was an ideal adventure playground for all kids of 
the neighbourhood, including slopes for first skiing at-
tempts and sledging, hiding places to play “doctor” and 
have your first smoke – not cigarettes, of course, but 
twigs of elder bush. Retrospectively, I think we were 
extremely lucky not to have found one of the many ex-
plosive war relics. 
My father worked as a salesman, and compared to 
others we did relatively well in the 1950s. He was a high-
ly talented piano and violin player, and I still retain re-
cordings of his usual training in Bach and Beethoven 
sonatas that accompanied my school homework. More-
over, we had weekly visits of friends who played string 
quartets or piano trios with my father. At the end of his 
life, he suffered from Alzheimer’s disease (AD), and one 
striking experiment confirmed more recent findings in 
brain research that the musical reminiscence bump 
survives longest in AD and arises strong emotions: in the 
chronic care institution where my father finally lived, a 
piano was existing, and once I took my father, then al-
ready in a very advanced disease stage, had him sit 
down and put his hands on the keys. As in the old times, 
he started immediately to play flawlessly, starting with 
Bach, then Beethoven and finally switching into a more 
popular Viennese waltz. All other patients and visitors in 
the hall immediately stopped to talk and listened. After 
some two to three minutes, my father suddenly stopped 
and appeared to be confused what was going on. There 
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was thundering applause, a final salute to this great 
musician, and tears were running down his face. He died 
soon thereafter. 
Unfortunately, I was much less gifted in musical in-
struments, but my father forced me to exercise every 
day at least for one hour, hoping to have me become a 
famous pianist that was his own but failed life vision. 
Always thinking of something else more interesting dur-
ing my daily practicing lessons at the piano, I can still 
hear him shouting corrections like “C sharp, not C” at the 
doorstep when he entered the house after work. It took 
me several years to convince him to allow me to stop 
playing, a decision that I regret very much now. I would 
love to play Mozart or Beethoven like I did as a child, but 
the rigid enforcement by my father erased or blocked all 
former training imprints in my brain. 
According to the traditional role model, my mother 
stayed at home and took care of my elder sister Monika 
and me (Fig. 1). Moreover, she was a housewife in the 
famous Bohemian tradition, with a cookbook that she 
wrote by hand after recipes told by her mother, an ap-
parently outstanding cook. I am still hunting for that old 
Bohemian cookbook in our family records, as I have 
become more and more interested in perfecting my own 
cooking. 
 
Fig. 1. The family in the mid-1950s. 
My father was also a good tennis player, and with 
tennis he was more successful to get me interested than 
with the piano. Indeed, I became a quite good junior 
player who could play competitively in a tennis club and 
even in the Austrian Boy Championship (age bracket 12-
14) where I was able to get into the quarterfinals. The 
tennis league tournament between clubs always includ-
ed one slot for a junior (up to an age of 18). Unfortu-
nately, I was the only junior of my club interested to play 
competitively, and this already at an age between 12 
and 14. At that early age, I already had to compete with 
18-year-old players. I mostly lost such matches, as my 
competitors were much taller and shot much stronger 
serves than I was able to do. This was one, but not the 
only, reason why I increasingly lost interest in tennis; the 
other was my awakening interest in girls that kept me 
more and more occupied in the later teenage years. 
Schooling 
My primary school, then of course gender-
separated, was also in the heavily damaged quarter 
where we lived first in Vienna, and I was fortunate to get 
a highly motivated and skilled teacher, Mr. Pokorny. I 
had no problems at all at school; already in kindergarten 
I had learnt unintentionally everything by listening and 
looking how my sister in her first class learnt to read and 
write. Later, I just listened during school lessons and 
remembered everything, without a need to repeat. At 
my age of 11, after the first year in a municipal high 
school, my father was so proud of my school perfor-
mance to have me switching to an élite gymnasium, the 
Theresianum that was founded in the 18th century by 
Empress Maria Theresia for the higher education of kids 
(of course only boys!) of aristocrats and public officials. 
At the time, it just re-opened again after WWII with a 
newly composed team of qualified teachers. It was a 
private boarding school where about one half of the kids 
– the interns – lived and slept there and had only occa-
sional permission to visit their families elsewhere in the 
country. The other half including me – the half-interns – 
stayed there for the day and went back to the family in 
the evening, then a highly unusual schooling schedule. 
Focus was on languages: starting with English at age 10, 
Latin was added after two years, French after two more 
years, and finally Russian after one more year. Apparent-
ly subconsciously, I decided that three foreign languages 
should be enough – my schoolmates obviously felt the 
same –, and took Russian quite lightly. Now I would be 
most happy if I could read Tolstoy in the original version, 
but all what has remained is the Cyrillic alphabet and a 
beautiful poem by Lermontov that we had to learn by 
heart. We had opportunities to practice all types of 
sports, including soccer and athletics fields in the huge 
park, and swimming in an indoor pool. So every early 
afternoon we rushed out for about two hours, mostly for 
playing soccer; this was a feeder for my lifelong love for 
sports and physical exercise in general. However, we 
also had some 2 or 3 hours of obligatory study time in 
the late afternoon. 
We were about 25 boys in our class. While most 
teachers were real experts in their field, some were less 
competent in paedagogic terms and even helpless in 
front of a bunch of merciless juveniles. The same went 
for the social knit among classmates – there were the 
usual fluctuating cliques that bullied outsiders. Now, 
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after more than five decades, I still feel ashamed not to 
have intervened then and would want to apologise to 
bullied classmates and teachers. Personally, I tried to 
steer clear of cliques without becoming an outsider, a 
habit of independence that I have cherished through my 
whole life. In 1964, at 18, we had our final exam (Matu-
ra, Abitur) where I got excellent marks. Our class quickly 
distributed to all corners of the world, and I met most 
classmates again only later at reunions after 50 and 55 
years. Some proved to have learnt little from life, playing 
the same clique stereotypes as during their teenage 
years. Astonishing but probably not so unusual. 
Why medicine? 
We had nobody with a medical background in the 
family. However, since I was some 10 years old, it was 
absolutely clear to me that I would become a medical 
doctor. I cannot remember a reason or triggering event, 
it was a matter of course. My career in (neuro)pathology 
started with the section of a sparrow who broke its neck 
by flying against a glass window, and that of a goldfish 
found dead in an aquarium. I just wanted to know how 
the inside looked like, and what was the very reason for 
death. This hunger for knowledge also accompanied my 
medical studies. I was totally immersed and – although I 
consider myself a true product of the 1968 generation in 
attitudes and spirit – in fact did not take much note of, 
nor participated in, the upheavals and demonstrations 
that paralysed university life in 1968. I kept this no-
commitment tradition in politics for long, with one no-
table exception: having just graduated as an MD, I par-
ticipated in a demonstration by doctors for better pay 
and working conditions. I felt it somehow obligatory to 
participate, now that I was a doctor myself. A few hun-
dred white-coated people ceremoniously marched down 
the famous Ringstrasse with banners and slogans, but 
increasingly my attention was drawn to what happened 
between demonstrators and onlookers. It was impossi-
ble to overlook the strong emotions elicited in surround-
ing spectators, shouting curses at doctors who were 
considered privileged over common people and earning 
too much anyway. It was frightening indeed: a spirit of 
outright hatred had seized many. With a feeling how 
easy control might be lost, I decided to never again go to 
the streets, valid until today. 
Medical study at the time had a relatively free 
schedule; you just had to pass some practical exercises 
and a defined sequence of about 20 rigorous oral exam-
inations, rigorosa. It was up to you how quickly you 
proceed. An important first step was the practical course 
in anatomy, with careful dissection of conserved corpses 
donated for teaching and scientific purposes. A group of 
6 to 8 students worked collectively on one corpse during 
most of the first year, dissecting muscles, nerves and 
blood vessels in the smelly atmosphere of the phenol-
formol fixative. We also had a special brain anatomy 
course with some dissection work that I found drab and 
uninspiring. Thank god, this impression did not last. 
Sitting for long daily hours around the corpses to 
study and dissect, it was the place to get familiar and 
make lifelong friends like I did, or, for many, to find 
partners to marry. The second year included histology, 
and I soon realised that I had some talent for that. I even 
gave a crash course to my best friend who initially was 
unable to recognise anything in microscopic prepara-
tions other than coloured spots. Later he became a radi-
ologist – maybe he unconsciously fled into a predomi-
nantly black-and-white world. After two and a half year, 
students switched to the clinical phase, starting with 
pathologic anatomy, pharmacology and then all major 
clinical disciplines. I became aware that I had no favour-
ite field at the time. In contrast, many mates were confi-
dent where to specialise. 
At exams, there were only three marks given, ex-
cellent, sufficient, and fail, and it was good or bad luck 
which examiner you got. I can remember almost every 
single rigorosum. The first one was in medical physics, 
after the first year. We were a group of no less than 12 
examinees, and it was surprising to me that I got a “suf-
ficient” already after a single question that I answered 
satisfactorily. I did not consider it relevant enough to 
make an effort to improve the mark. The next exam was 
in chemistry, with a professor who was probably the 
most feared examiner of the medical faculty. He was 
reportedly proud of having a low pass rate, particularly 
with female students, in my memory the only gender 
bias that I encountered when studying. My first question 
was about coenzyme A, a large molecule that I could 
describe quite well. Then it was me who asked whether I 
should draw the formula – the professor reacted sur-
prised and agreed. I did it perfectly but was unsure if the 
professor liked it or not. After quite some more demand-
ing questions, he gave me an “excellent”, my first one in 
a row until the end, as I could manage to pass all subse-
quent rigorosa with the best mark. This appeared to be 
relevant; I had been told that I could become a candi-
date for a “promotio sub auspiciis praesidentis rei publi-
cae” and be rewarded with employment in a public insti-
tution of my choice, at a time when many medical grad-
uates were working as “guest doctors” without salary. 
Unfortunately it finally turned out that the single lower 
mark in the initial physics exam did not allow such a 
distinction. However, I made my way without it. 
At summer holidays, I had some 3 months to spend 
until autumn when university life would start again. I 
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had bought a small rubber boat with outboard motor 
and took unforgettable weeks with a group of friends on 
the Greek island of Thassos. Days were filled with sun-
bathing, retsina and ouzo drinking, tavli playing, swim-
ming, snorkelling and fish hunting with a handy harpoon, 
then still allowed in the Mediterranean. We even vowed 
to ourselves to live only on what we would be able to 
hunt. However, fish were mostly lucky, as we said, in fact 
much too fast for us, and escaped our clumsy attempts. 
Once we mistook a seagull for a tasty duck and were 
disgusted to finally have an after-feathering tiny bird to 
feed four hungry pals. Thus the vow had to be broken 
soon after arrival, and we raided the next inn to engulf 
mountains of souvlaki meat with tsatsiki. 
In addition to these summer delights, I worked as 
tour guide during other holiday breaks. Usually I had a 
busload of Austrian tourists, mostly high school teach-
ers, a rather demanding clientele. I was required to exe-
cute by myself the local travel organisation with hotels 
and restaurants, as well as to provide the explanations 
at sightseeing spots. Of course I had to make detailed 
preparations and wrote my own manuscript for the 
whole travel schedule; thus I learnt a lot about countries 
like Italy, France, Spain, Portugal, Morocco, USA, Mexico 
and Guatemala. A great personal interest in everything 
connected with history has emerged from these activi-
ties. My favourite trips were those to the absolutely 
stunning sites of pre-Columbian cultures in Central 
America, in particular places like the then recently dis-
covered Palenque, Tikal or Teotihuacán, and the unbe-
lievable archaeological museum in Mexico City. Some-
thing else that I learnt during the several weeks of stay-
ing together with up to 50 people was group dynamics 
and how to handle critical situations and conflicts that 
emerged quite regularly. Christmas, Easter and parts of 
summer holidays were spent that way over subsequent 
years, and I could earn enough money to buy my own 
car, first a Fiat Cinquecento and later a Volkswagen bee-
tle, something quite unusual for a student at the time. 
Why Neuropathology? 
While it was obvious to me since childhood to have 
medicine as my lifeblood, the choice of neuropathology 
was just by chance. My exam in neurology and psychia-
try, then still combined and scheduled about half a year 
before graduation, was decisive for my further career. 
The professor, a highly respected psychiatrist with a 
remarkable empathic style, seemed to be pleased by my 
performance and asked about my future plans; if I were 
interested in his field, I should meet him again after the 
end of my study. Of course I was more than delighted, as 
officially recognised training positions in a given speciali-
ty were then almost impossible to get, and I envisaged 
myself already as renowned psychiatrist. Soberingly, 
when I came back half a year later with high expecta-
tions, he did not appear to remember and emphasized 
the existence of a long cue of candidates lining up for 
still unpaid positions. However, I was categorical in that I 
would never, never work without pay, as I was still living 
with my parents and wanted desperately to escape from 
that crowded setting. Hearing that, he asked for my 
further interests and recommended to make a visit to 
the Neurological Institute (NI) where my preference 
should be met best, in his opinion. 
The NI of the Medical Faculty occupied a full floor 
in a building shared with histology at Schwarz-
spanierstrasse, in a block where most pre-clinical insti-
tutes were located, in about mid-distance between the 
main University building at Ringstrasse and the General 
Hospital (AKH). Since NI was then not involved in teach-
ing to medical students, I had passed by its huge glass-
and-white wooden doorway and large lettering of its 
name many times without entering, when I was on my 
way to attend histology courses upstairs. None of us 
students had any idea what was going on behind its 
doors. Anyway, I made an appointment with its director, 
Professor Franz Seitelberger, and he welcomed me in his 
office, with his desk at the very end of an impressively 
large room. He asked about my interests, and I told him 
that at the moment I was reading a booklet about bio-
logical psychiatry. I read there the description of a 
(chromatographic, I learnt later) “pink spot” in urine that 
was claimed as specific for schizophrenia. Wow, this was 
it! I was absolutely fascinated – an extremely complex 
psychopathology condensed into a single spot. What 
could be more exciting to study?! Prof. Seitelberger 
listened patiently and asked me about many additional 
private topics like family, hobbies, sports etc. that I con-
sidered completely irrelevant. Finally he said, yes, there 
is a position available. While he mentioned that my pink 
spot fascination was in neurochemistry, an area also 
covered by the institute, he emphasised that I would be 
required to start in neuropathology, a discipline that 
analyses structural changes in the nervous system during 
disease, something absolutely basic to all studies of 
nervous system disorders. Of course I had nothing to 
object, and we agreed upon my entry to the institute 
later that autumn. Surely, I remembered to have already 
liked histology during my study, but wasn’t aware then 
which chance I would get from the very start: it would 
become an absolutely perfect fit for my interests and 
abilities – or did neuropathology choose me? Looking 
back on my professional life, I cannot imagine something 
better suited to satisfy a hunger for knowledge and un-
derstanding, to experience case histories to evolve like a 
thriller, to feed any curiosity, to keep your inner fire 
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burning and to help transmitting scientific fascination to 
others. And the best thing was that it was not only much 
fun and satisfaction but – very important for me as a 
young guy who would soon have his own family – you 
are even paid for it! 
The early years 
 
Fig. 2. Bust of Heinrich Obersteiner, having its traditional place 
immediately behind the glass-wooden doorway of the Neuro-
logical Institute (NI). My small kids occasionally visited the NI 
and were greatly impressed by this bust. After asking once to 
be allowed to tweak the stony cold nose, they did it again 
every time they visited. After NI’s move to the General Univer-
sity Hospital (AKH) in 1993, the statue was re-located to the 
Honour Courtyard of the University of Vienna building at Ring-
strasse. 
When I started to work in the NI on Oct. 1st, 1971, 
nobody could foresee that I would stay there uninter-
ruptedly until my retirement, on the day exactly 40 years 
later, a straightforward but highly unusual curriculum 
vitae for a scientific researcher. I realised only later the 
eminence of the NI as the first multidisciplinary institu-
tion of the neurosciences in the world. Founded in 1882 
by Heinrich Obersteiner (Fig. 2) and blossoming under 
Otto Marburg until the collapse of the Medical Faculty 
by the advent of Nazism, it had become a model for such 
institutes elsewhere, from Fukuoka in Japan to Montre-
al, New York and Philadelphia. Absolutely unique was 
NI’s library that contained an unrivalled treasure of neu-
roscience books, in particular from the 19th century. It 
was Franz Seitelberger’s merit to have re-built the NI 
after WWII, from practically scratch with only a single 
half-time position, to a nationally and internationally 
recognised centre of excellence when he became profes-
sor emeritus in 1986. 
At my entry to the NI, it was a composite of several 
disciplines led by distinguished scientists (Fig. 3). Tumour 
and autopsy neuropathology was led by Kurt Jellinger; 
neuromuscular neuropathology by Elfriede Sluga who 
mainly worked the NI’s own electron microscope; neu-
ropathology of the vegetative nervous system by Gustav 
Lassmann; neurochemistry by Hans (Hanno) Bernhei-
mer; neurophysiology by Hellmuth Petsche; and neuro-
linguistics by Karl Gloning. Soon another young aspiring 
researcher arrived, Hans Lassmann, to establish a lab of 
experimental neuropathology. 
In the NI, I was supposed to become Kurt 
Jellinger’s assistant and, over some 3 years, was given a 
unique chance to familiarise with neuropathology in my 
very personal way, by re-examining the huge histopatho-
logical collection and compare my fresh impressions 
with the available written reports. This autodidactic 
learning style was well in agreement with both my and 
Kurt’s self-absorbed approach to work. For about half a 
year, I did not really know how to appropriately re-
examine an autopsy case with very large-sized micro-
scopic sections. It took me half a day to microscope such 
a section, as I mainly used high magnifications and even 
the oil immersion objective! No wonder that I saw an 
astonishing new universe of structures of amazing 
shapes, sizes and colours. After about a couple of weeks 
of such microscoping, I saw something really bizarre, a 
rounded body with a strange and multicoloured struc-
ture. Consulting not only oil immersion but also text-
books, I could not find anything that resembled this 
discovery. I got very excited and immediately informed 
Prof. Seitelberger who, after a shared microscoping 
session in his office, agreed about the novel character of 
this strange body. He even suggested to publish it to-
gether, and advised me to take microphotographs. Of 
course I had no idea about microphotographing and 
admitted that. No problem, he replied and pointed to a 
small mountain of something hidden under a huge dusty 
cover in one corner of his room. He would do it himself, 
as that photomicroscope was the very best in the world. 
I should come back in about one week. So I asked after 
one week and weeks thereafter, but he always answered 
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Fig. 3. People working at the NI in the early 1970s. 1st row, sitting from left: Lassmann sen., Petsche, Seitelberger, Jellinger, Gloning; 2nd 
row: 4th from right, Sluga; 3rd row at left Auff; last row, 2nd from left Budka, 4th Bernheimer. Unnamed persons include the indispensable 
workforce of technicians and secretaries. Note the distinctive traditional hierarchy, as evident from the arrangement of this photograph, 
that then imbibed NI’s atmosphere everywhere. 
to have been too busy to do it. Then, there was no need 
anymore to document the strange body: I found out by 
myself that it was a corpus amylaceum, an extremely 
common structure produced by astroglia, occasionally 
looking a bit unusual. 
As working space was scarce in and between the 
lab rooms crammed with instruments and equipment, I 
was given a desk and microscope within the Lecture Hall, 
a huge room with large windows and old-fashioned 
seating rows (Fig. 4). Already a postdoc from Japan had 
arrived, Riki Okeda, a new friend who later became pro-
fessor of neuropathology at Tokyo Medical and Dental 
University. Another close friend, Ferenc Garzuly who 
became Head Neurologist in Szombathely, Hungary, 
completed our trio there. It was much fun – we had 
small parties, Riki used to play the violin, and we took 
everyday a nap after lunchtime snoring in the seat rows. 
When I recently told Ferenc that I am writing up my 
memories, he obliged me to mention my first day in the 
Lecture Hall when I drew onto the chalkboard a cell 
nucleus to demonstrate a “wonderful” change, but both 
Ferenc and Riki could not detect anything unusual. Yes, 
already on my first day I thought to see something spe-
cial and difficult for others to see. Moreover, according 
to Ferenc, I must mention to have had a green metal box 
with some gadgets that made enough noise to prevent 
both of them from sleeping in the seat rows. 
Indeed, it was a great – and by then rather unusual 
– tradition to always have several postdocs at the NI, in 
particular from Japan. This started already in the early 
20th century when the famous poet Saitṓ Mokichi stayed 
for 2 years at the NI and wrote some haiku poems there, 
including so-called tankas that are limited to 31 sylla-
Free Neuropathology 1:15 (2020) Herbert Budka 




bles. One tanka was written about Prof. Obersteiner 
(translated from German to English by myself): 
„Unerwartet ”Unexpectedly 
trat der alte Lehrer stepped the old teacher 
neben mich next to me 
mit großer Einfachheit with great simplicity 
munterte er mich auf.“ he encouraged me.” 
 
Another tanka was written about Prof. Marburg: 
„Vor meinen Augen ”In front of my eyes 
steht stands 
Professor Marburg, Professor Marburg, 
dem ich whom 
mit bebendem Herzen with trembling heart 
meinen Dank ausdrücke.“ I express my thanks.” 
Over several decades, numerous postdocs have 
been trained in neuropathology in the NI (a long list of 
names that I can remember is attached at the end of this 
article). In addition to many Japanese colleagues (who 
have organised a “Vienna party” whenever I made a visit 
to Japan), we intentionally kept traditional connections 
to our neighbouring countries, in particular to those that 
were behind the iron curtain at the time, such as Hunga-
ry, Poland and Yugoslavia. My first student was a beard-
ed guy always wearing black spectacles, Pawel P. Liberski 
from Łodz, Poland, who was interested to study a rare 
disease named after Creutzfeldt and Jakob since his first 
visit in 1979; he became a friend and collaborator during 
his regular subsequent visits. Two more persons to men-
tion are Takeshi Kurata, professor at the NIH in Tokyo, 
with whom I published work on virus detection in brain 
and who also became a friend and regular visitor until 
today, and Ichiro Akiguchi, professor of neurology at the 
University of Kyoto, another regular visitor and collabo-
rator on the neuropathological work-up of the commu-
nity-based VITA study on ageing. He became a friend 
and invited me several times to stay for up to two weeks 
in Kyoto, in addition to several trips that I made to all 
parts of that captivating country. This was to pour oil 
onto my fire for traditional Japanese lifestyle and culture 
such as food and onsen baths, as well as Buddhist tem-
ples, Shinto shrines and amazing Japanese gardens. 
 
 
Fig. 4. The Lecture Hall of the NI in 1991 during an informal meeting. Hans Lassmann at far left, the author at right in front, Thomas 
Berger, the present Director of the Neurological Clinic of the Medical University Vienna, in rows at right, 3rd from front. 
Free Neuropathology 1:15 (2020) Herbert Budka 




After a couple of years, I was allowed to write his-
topathological reports on neurosurgical biopsies in 
Kurt’s absence, and autopsy reports on less complicated 
cases, almost exclusively strokes. I believe there are few 
neuropathologists in the world (of course with the ex-
ception of Charles Miller Fisher) who had the opportuni-
ty and gusto to study stroke cases in great detail from 
the start of their career, and my first book chapter publi-
cation was on the neuropathology of cerebrovascular 
diseases. I am still proud of that early article written in 
German in the pre-MRI era, now forgotten since dec-
ades, because it comprises interesting and original data 
on the infarct patterns resulting from verified occlusions 
in the carotid-media system (Fig. 5), demonstrating high 
interindividual variability and lack of any predictable 
correlation between site of infarct(s) and site of occlu-
sion [1]. At that time, I was unaware of the importance 
1) to publish in English, 2) to publish in a peer-reviewed 
journal rather than in an obscure multi-author book, and 
3) of the relevance to consider bibliometric data such as 
the impact factor. 
 
Fig. 5. Topographical patterns of brain infarcts in 196 autopsies 
with verified occlusions in the carotid-media vascular supply. 
Among the 23 patterns that highlight the eminent individual 
variability by site and extent of brain infarction, the percentage 
of the four most frequent patterns (total, subtotal, central and 
peripheral media infarcts, in sum 71%) are indicated in red. 
Vascular areas: A = anterior cerebral artery, M = media, P = 
posterior, ChA = A. choriodea anterior, Cp= A. communicans 
posterior. Modified from ref. [1]. 
In that early time, one of my few responsibilities 
was taking macroscopic photographs during brain cut-
ting sessions, taking place every Wednesday morning 
(Fig. 6). I made several experiments to optimise that 
type of documentation: the best background for colour 
contrast was finally settled as a dark blue, and whole 
brains and brain slices were arranged on a glass plate 
some 10 cm above the background cloth, in order not to 
have any interfering shadows when the illumination was 
from both sides. 
 
Fig. 6. Brain cutting session with Prof. Seitelberger in the 
1980s. Note the numerous fixed brains in glass jars in the back 
– and the formal ties everybody wore then during work. 
One more responsibility was to visit the Depart-
ment of Pathology every early morning, in order to de-
termine which autopsy brains would be interesting and 
important enough to be fixed for neuropathology. At 
that time, autopsies still numbered more than 2000 per 
year, and not every brain could be fixed and examined. I 
still remember vividly the boss of the autopsy suite, Prof. 
Kucsko, in the beautiful old building of the Institute of 
Pathology (now the Institute of Brain Research) where 
already Carl von Rokitansky had worked. Kucsko was a 
gaunt chain smoker always with a cigarette butt on his 
lips during a whole section. He was an extremely experi-
enced pathologist who taught me great respect for the 
autopsy as golden standard and one of the most difficult 
tasks in medicine, less with regard to skills but more to 
generalised knowledge, experience and “feeling”, a 
talent somewhat difficult to explain by words. Another 
lesson I learnt from him is the importance of a very de-
tailed macroscopic examination – what you do not see 
or at least suspect at gross dissection, you have little 
chance to find by microscopy. Initially he had little con-
sideration for that young guy interested only in the 
brain. However, once I told him that I found small cancer 
metastases in the brain when the body section by him 
had not found anything. Can’t be, he snapped, and went 
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back to the inner organs that fortunately had been fixed 
and were still available. He called me back in the after-
noon to confirm that, indeed, no tumour was found in 
the body. When I stayed firm with my metastases, he 
went back again to the fixed organs and finally found, 
after 3 days of cutting almost every millimetre, a tiny 
scar carcinoma of the lung. After that I had some reputa-
tion with him and was free to express my wishes for 
neuropathology. 
This came in handy when Kurt ordered me to 
freeze fresh brain slices from then relatively many 
Creutzfeldt-Jakob disease cases autopsied in Vienna. I 
had to send them on dry ice to D. Carleton Gajdusek at 
the NIH in Bethesda, for transmission experiments into 
non-human primates. I did that without any special safe-
ty precautions that then were unheard of, and retro-
spectively I am not sure whether I touched these brains 
by bare hand or not. I was later very proud to have con-
tributed some part, even when minuscule, to Carleton’s 
Nobel prize in 1976. 
Kurt Jellinger left the NI in 1975 for a position of 
Head of a Department of Neurology in the municipal 
Lainz Hospital in Vienna where he could do both clinical 
neurology and neuropathology. Of course, this was a 
severe blow for the NI, but in particular for me, as sud-
denly all responsibilities for diagnostic neuropathology 
were mine. Kurt was the collector type of neuropa-
thologist who always had large case numbers available 
for his research. During my years with him, the number 
of neuropathological autopsies was as high as 600 per 
year, and neurosurgical biopsies numbered around 
1000. Only he could handle such a volume alone or with 
one assistant, and when he left, I – a newcomer with 
only 3.5 years in business – was almost alone to shoul-
der such tremendous quantities. I decided quickly to give 
priority to tumour pathology, and for several years I was 
unable to keep up with the flow of autopsy cases even 
when, by necessity, they had to be reduced to a signifi-
cant extent. 
To lose Kurt at that time was still more painful to 
me, as I just had entered into clinical training. Tradition-
ally all MDs of the NI had training in a clinical speciality 
(to become Facharzt or consultant), usually neurology 
rather than pathology. Neuropathology became a speci-
ality of its own in Austria only later, a development that I 
could push forward to a significant extent. To become a 
specialist in neurology and psychiatry, I started a year of 
internal medicine in 1974, psychiatry in 1975, and neu-
rology in the following 4 years. It had been agreed be-
forehand with the directors of the respective clinics that 
I would do clinical training in the mornings until noon or 
early afternoon, and then continue my work in the NI 
where I kept my official position. Under these circum-
stances, it is not difficult to imagine what workloads I 
had to face when returning to the NI in the afternoon 
and working into the night. I soon became unsure 
whether I could, and should, carry on this double burden 
at all, a feeling of uneasiness and uncertainty that domi-
nated the second half of my 1970s. 
Even under these extremely difficult circumstanc-
es, I soon realised that research was pre-eminent in 
importance for the career. As a relative newcomer, I was 
not sure in which topic I should invest, in preparation for 
the next step in career building, the habilitation (lecture-
ship, to become Dozent). I had spent most of my year in 
internal medicine in haemato-oncology, then led by the 
very amicable Prof. Josef Kühböck, and could witness the 
successes as well as complications of then modern ag-
gressive and even prophylactic chemotherapy of leu-
kaemia and lymphoma. In parallel, I could collect a small 
but very interesting and then timely series of brains of 
patients who unfortunately had died with such compli-
cations. Thus I published “The pathology of encephalo-
pathies induced by treatment or prophylaxis of neo-
plastic lesions of the nervous system”, again as a book 
chapter that I was proud of but became quickly forgot-
ten; however, this time I wrote in English [2]. Another 
potential topic that I considered for habilitation was the 
neuropathological substrate of collagen vascular disease, 
again a publication that I was very happy with but went 
practically unnoticed, even in an American journal [3]. 
Finally, publication of the first description of the adult 
type of adrenoleukodystrophy (ALD), what is now called 
adrenomyeloneuropathy (AMN), became a highly cited 
paper for the first time [4]. 
In order to be successful, it would be particularly 
important to introduce to neuropathology, as performed 
at the NI, new investigations, such as CSF cytology, and 
techniques such as immunohistochemistry (IHC), in addi-
tion to an interesting topic and adequate material to 
study. I developed CSF cytology with a special sedimen-
tation device, examining CSF samples that I brought to 
the NI from patients with leukaemia or lymphoma. We 
counted the number of cells, sedimented them and 
made a Giemsa stain, later also occasional IHC labellings. 
For IHC, I started with visualisation of immunoglobulins 
(Igs), because good antibodies were then available, to be 
used in direct or indirect immunofluorescence. Astro-
cytes were usually full of Igs, but soon I realised that no 
really interesting problem was to be solved with these 
antibodies. Fortunately, at that time Larry Eng had just 
purified glial fibrillary acidic protein (GFAP) as astroglia-
specific marker and raised antibodies against it, and 
Lucien Rubinstein – then with Larry in Stanford – had 
successfully made first immunostainings on brain tu-
mours. Thus the opportunity emerged to introduce IHC 
for GFAP to the institute, at the start still with immuno-
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fluorescence, soon thereafter using Ludwig Stern-
berger’s elegant peroxidase-antiperoxidase (PAP) tech-
nique. Over the next decades, IHC (and to a lesser de-
gree nucleic acid in situ hybridisation, ISH) would domi-
nate most of, if not all, my diagnostic and research work 
in neuropathology, in particular in neural tumours, infec-
tions and neurodegeneration. Of course IHC was also 
essential for neuromuscular biopsies, but in the old NI 
they were Elfriede Sluga’s domain, and I entered that 
field only after she moved, like Kurt earlier, to a position 
of Head of a Department of Neurology in the municipal 
Wilhelminen Hospital in Vienna. Much of this work on 
new techniques must be credited to the indispensable 
help of our amazing laboratory technicians who patient-
ly and persistently developed perfect (immu-
no)visualising systems in pioneer experiments: Mrs. 
Helga Flicker, NI’s all-time good spirit and helping hand 
who virtually accompanied my whole career in Vienna, 
Mrs. Irene Leisser who arrived only shortly later, and 
from the millennial years onwards Mrs. Gerda Ricken. 
While they kindly agreed to co-author the publication of 
some of their successes, in fact they should have been 
on the author ticket of all respective papers. Having said 
this, any thanks to them would be incomplete without 
the recognition of work that was accomplished also by 
other technicians, secretaries and support staff – I was 
extremely lucky to have such people to work with. 
Despite all troubles, my early years in neuropa-
thology ended successfully, in 1980 with recognition as 
clinical specialist (Facharzt) in neurology and psychiatry, 
a step that also promoted me from assistant to consult-
ant (Oberarzt), and further on in 1982 with my habilita-
tion (lectureship) in neuropathology. The title of my 
habilitation thesis was “Viral Diseases of the Nervous 
System” and combined 3 original papers [5-7] on viral 
antigens in herpes simplex virus (HSV) encephalitis, ra-
bies and subacute sclerosing panencephalitis (SSPE). I 
was more than happy that the exhausting time of riding 
two horses at the same time has ended, even when I 
liked clinical work very much. So it was only later, during 
my midlife crisis, that I considered to go back to clinical 
medicine. 
The second family 
The turbulent first decade of my professional life 
coincided with establishment of my own new family. I 
met Christine at the CSF lab of the Neurological Clinic 
where she worked as technician, and we married one 
year later. Philipp was born in 1974, Julia in 1977, Daniel 
in 1979, and Rafael in 1980. With these kids born in a 
short period, my wife had stayed at home and it was not 
that easy for me, as university assistant with a very me-
diocre salary, to sustain a family of 6. Our financial situa-
tion improved somewhat when Prof. Seitelberger al-
lowed me to make forensic expertises that are remuner-
ated additionally. That activity turned out to be demand-
ing but most rewarding intellectually and scientifically, 
and I have continued it up to this day – something that 
always has enabled me to keep my fascination for neu-
ropathology alive. 
With all my obligations, it was very difficult to 
spend time with the family. I devoted all weekends and 
holidays to them, but during the week I used to come 
home from work when most if not all kids were already 
asleep. We tried to remedy the situation by establish-
ment of a weekly family day when I would come home 
earlier, play, do storytelling and reading with the kids. 
Nevertheless, I used to have a guilty conscience about 
my inability to dedicate enough time that a family with 
children would deserve. Moreover, we always had dogs 
that became full family members as well, the wire-
haired dachshund Ilko at start, followed by Polski Ow-
carek Nizinny (Polish Lowland Sheepdog) Betsy and later 
Hovawart (“farm watcher”) Debbie. Although dogs snip 
away further bits from your time, they are beautiful and 
most grateful creatures enriching and rounding up any 
family; they love you unconditionally, whether you de-
serve it or not. 
All my kids grew up to become successful profes-
sionals and, more importantly of course, happy, amica-
ble and easygoing personalities to be proud of: Philipp 
became an established lecturer and researcher in social 
and cultural anthropology at the University of Vienna 
and Free University Berlin, specialising in the sociocul-
tural consequences of digital media and technologies, 
living in a harmonious partnership with Julia, an online 
media editor. My daughter Julia became an internation-
ally highly respected Egyptologist who repeatedly has 
performed excavating campaigns in Egypt and Sudan 
and has won two extremely competitive ERC research 
grants; she is now Professor of Egyptology at the Lud-
wig-Maximilian-University Munich and in a partnership 
with Tanja, a kindergarten supervisor. I admire and envy 
her, as she is rapidly running up to the number of entries 
on the internet that I have. Daniel became an expert, 
art-prize-winning graphic designer and video producer, 
happily married to Caroline, a hospital physician; they 
have delightful Ellie and are expecting their second child 
soon. Rafael succeeded in establishing his own media 
and marketing company to organise various types of 
events, from business celebrations to pop concerts, 
living in partnership with Nathalie, a journalist, and their 
two gorgeous girls Lori and Noemi. Looking back when 
getting old, it is most gratifying to see a sequence of 
generations that carry on the spirit and ideas that you 
have valued highly during your life, even when my small 
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wish, to have one of my kids enter medicine, has not 
realised (but I still have such hopes for my fifth child, 
Natalia). 
The difficult family years had one casualty, as it 
turned out only later. My marriage broke apart, fortu-
nately only when all kids had already left our home. 
Certainly a divorce, and mine was a bitter and battled 
one, is a sad event in any life. However, to quote Paul 
Watzlawik, there is nothing bad in life that doesn’t have 
something good as well: my longstanding guilty con-
science about the inability to dedicate enough time to 
the family fell apart quickly, and I suddenly felt com-
pletely free, a feeling of happiness and contentment that 
I had missed since decades. Of course it is a very selfish 
thing to be back to independence, but my advice to 
everybody is to listen to one’s very gut feelings how you 
really sense your being. I discussed the situation that I 
went through with friends, and some of them had simi-
lar constellations; a couple of them did the same as I – 
and these made identical experiences. In the following 
years I was free to work as I wanted, to travel around as 
I wanted, and to have no private commitments at all. 
The most important matter, however, was continuation 
of my good relation with all children despite the divorce. 
Going international and something 
other than work 
Totally focused on work and a growing family, I had 
neither time nor interest for the many distractions 
young people had at the time. A somewhat more re-
laxed schedule was possible when I went to scientific 
meetings and congresses outside of Vienna. From early 
on, I tried to attend International Congresses of Neuro-
pathology (ICNs), the biggest event in our field. My first 
ICN was in 1974 in Budapest, and the technique that 
dominated most investigations was electron microscopy, 
with “virus-like structures” almost everywhere. Brain 
tumour pathology, for the very last time, had retained a 
strong influence by Spanish and Latin American re-
searchers using sophisticated gold and silver techniques 
as basis for classification – we dubbed a symposium 
chaired by the famous Professor Moises Polak in Buda-
pest as “metal mining” meeting. Within the few follow-
ing years, the centre of gravity shifted to the Anglo-
American tumour tradition, mostly represented by the 
landmark book editions by Dorothy S. Russel and Lucien 
J. Rubinstein, then the bible and only comparable in 
impact to the present WHO Classification of Tumours of 
the Central Nervous System. When the ICN in 1982 was 
held in Vienna, I was charged with organising a tumour 
slide seminar together with Lucien. It was an unbelieva-
ble luck and privilege to meet, discuss and work with 
such a giant. I visited him in Charlottesville, VA, well 
before the ICN in order to select interesting candidate 
cases to present. What impressed me most was his 
memory with the incredibly huge collection of ”similar” 
cases that he had at his fingertips – whatever you 
showed and asked, he immediately answered convinc-
ingly with demonstration at the microscope of a similar 
case. By the way, he was equally impressive as an im-
peccable British gentleman (although originally from 
Belgium), almost seeming misplaced in the US (he could 
have been the topic of Sting’s song ”Englishman in New 
York”, in particular the quote “If manners maketh man, 
as someone said, He's that hero of the day”), as a true 
polyhistor with amazing knowledge of art (he decorated 
his home with stunning huge tapestries by Jean Lurçat), 
and as husband to a most charming and warm-hearted 
wife, Mary M. Herman, also a neuropathologist and his 
closest collaborator, with particular EM expertise. 
In addition to ICNs that are only held every 3 or 4 
years, I regularly attended annual meetings in Austria’s 
great neighbour, Germany, i.e. those of the German 
Society of Neuropathology and Neuroanatomy. In addi-
tion to a much broader scientific scope than what we 
had in small Austria, those meetings were nice social 
events to meet new and old friends, in a relaxed atmos-
phere that sometimes culminated in rather hilarious 
sessions, unexpectedly in business sessions of society 
members. I remember some colleagues with unbelieva-
ble humour, such as an extremely witty guy from Frank-
furt, Prof. Thomas. Everybody was already holding back 
laughter when he started to speak and made bizarre 
suggestions. One of the early German meetings that I 
attended, in 1979, was held together with the Polish 
Society of Neuropathology in Cracow. I went there by 
car, then quite a trip across countries behind the iron 
curtain, and highways were still non-existing on that 
route. I went there also to have a glimpse of Cieszyn / 
Těšín / Teschen from where my grandfather had migrat-
ed to Vienna. I arrived there late in the evening, and the 
impression was appalling, as the town appeared com-
pletely dark, depopulated and dilapidated; in my 
thoughts I congratulated my grandfather to have es-
caped from there. For fairness: when I came back 40 
years later, it was a very nice and well-maintained Cen-
tral European town with a huge historical main square, 
deserving a visit. 
The meeting in Cracow was nice, the city very 
beautiful and full of history, but I looked also elsewhere 
and soon found out that Auschwitz was close. I thought 
that it would be obvious, even obligatory, to make a visit 
to such a historical site nearby. Therefore I asked at the 
German society members’ business meeting about the 
tour that certainly would be organised there and wheth-
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er a place was free for me to join. Totally naïve as a 
youngster who was spared from the horrors of the Nazi 
period by the blessing of late birth, I did not expect that 
my question would raise any nerve, but it did. There was 
icy silence, and nobody wanted, dared, or was interest-
ed, to answer. My god, I thought, this was then at least 
34 years ago. Good lesson for my naïvety. It was only 
later that I learnt of the involvement of some Austrian 
and German neuropathologists in Nazi atrocities, but 
also of the admirable efforts by some, in particular by 
Prof. Jürgen Peiffer from Tübingen, to elucidate and 
document the disastrous deviation of our discipline 
during that period. Twenty years later, after I became 
director of the NI, I had to re-visit and clean up such 
involvement in our own backyard. 
To some degree, the visit to Auschwitz changed my 
life. The main camp, Auschwitz I, had been restored as a 
museum that was well maintained and diligently docu-
mented, with all the horrors of gallows, execution walls, 
mountains of hairs, spectacles or children’s shoes, all 
difficult or impossible to stomach. However, the exter-
mination camp proper, Auschwitz II – Birkenau, was 
different; it was kept as it was, without any restoration, 
additions or changes, giving it a surreal atmosphere of 
the still present, villainous evil as well as persistent ago-
ny. I spent the whole day there, wandering around com-
pletely distraught, aimlessly and disoriented, sometimes 
hallucinating victims’ whispers. It took me a few days to 
get over this experience, and I decided for myself to 
contribute my very own, very personal, however small, 
part to have that never to happen again. Back to Vienna, 
I identified Amnesty International (AI) as perfect fit for 
my abilities and intentions, and founded the first AI 
Medical Doctors’ group there. AI’s remit is to fight hu-
man rights abuses, torture and death penalty every-
where in the world. Then it was still cold war – the fight 
against lawbreakers and offending countries was three-
tiered, politically balanced between the West, countries 
behind the Iron Curtain, and those in the developing 
world. Medical doctors had a definite role in that fight. 
As examples, our group documented objective signs of 
torture in victims who were lucky to have escaped to 
Austria during and after the Iranian revolution or from 
Latin American dictatorships. I also participated in mis-
sions that investigated and reported on conditions of 
prisons in countries accused of abuses in jail, another 
disturbing personal experience. Since AI does not pro-
vide direct treatment to affected people, Siroos Mirzaei, 
a radiologist and amicable friend with Iranian roots, and 
I decided later to proceed with an organisation called 
Hemayat (meaning help or protection in Arab and Per-
sian) that was to provide free psychological and physical 
treatment for victims of torture in Vienna. The Balkans 
war of the 1990s created many, often too many, victims 
in need of help. In this year, Hemayat celebrated its 25th 
anniversary – and is still necessary to exist, maybe now 
more than ever. 
The HIV onslaught 
By the first half of the 1980s, I had investigated the 
regional and cellular tropism in a range of viral infections 
involving the nervous system, but nobody had previously 
assumed that this knowledge would become very helpful 
when, since 1981 in the USA and then in Europe, a new 
disease appeared apparently out of the blue, acquired 
immune deficiency syndrome (AIDS). In Austria, we had 
our first autopsies from early 1983, and we were well 
aware that appropriate safety measures had to be ap-
plied, although only later that year Luc Montagnier (with 
Françoise Barré-Sinoussi, also sharing with her the Nobel 
Prize in 2008) isolated the culprit as lymphadenopathy-
associated virus (LAV), or HTLV-III as Bob Gallo called it, 
or human immunodeficiency virus (HIV) since 1986. I 
could meet and listen to these two eminent researchers, 
both of whom gave the immediate impression to be 
characters as different and irreconcilable as possible to 
imagine, maybe one of the reasons for their bitter fight 
for recognition as HIV discoverers and exploiters. When I 
had examined a small series of AIDS brains, I realised 
there was something going on in addition to the by then 
well known opportunistic infections, an inflammatory 
process with multinucleated haematogenous cells as 
hallmark. I published that in 1986 [8], after having de-
scribed with Paul Kleihues from Zurich another charac-
teristic type of pathology, a progressive diffuse leu-
koencephalopathy [9]. In those years, I was busy with 
presenting my HIV data at lectures and meetings. After 
such a meeting in Germany, a well-known professor took 
me aside and asked: “Well, I also have a series of HIV 
brains but have never found the multinucleated cells you 
describe!”. I replied by suggesting to show me slides of 
whatever case he wanted to discuss, and it was perfect 
luck for me to find almost immediately these cells in his 
own slides. “Oh, they look like this, I didn’t expect that!” 
was his reaction. Yes indeed, these cells may look 
somewhat strange occasionally and differ from other 
types of multinucleated cells. One lesson that I took 
from that and similar situations was my absolute belief 
in the old wisdom that there is a lot to see when you 
look, and in old-fashioned, analogue microscoping for 
training, when one can play around with focus over 
several planes, something that is difficult to impossible 
to experience with simple pictures or even more ad-
vanced digital slide processing. So up to today, I refuse 
to give diagnoses just on cabled images. 
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Exactly at that time I met Gianriccardo Trabattoni, 
an extremely big-hearted neurologist from Parma, Italy, 
having striking similarities in physiognomy and humour 
with Woody Allen. He asked whether I would be inter-
ested to study autopsy brains from the AIDS epidemic in 
Italy. An enormous tragedy was then occurring in Milan, 
with many deaths every day. Now this sad history re-
peats itself there, with the difference that SARS-CoV-2 
kills preferentially old people, whereas HIV killed indis-
criminately, including many youngsters. Yes, no ques-
tion, I was interested to study those brains, and Gianric-
cardo spent subsequent weeks in smuggling caseloads of 
formol-fixed brains in jam glass jars by rail across the 
Brenner frontier from Italy into Austria. At that time, 
there were still border controls, and I wondered what 
would happen if he would have had his luggage con-
trolled – I had nightmares of press headlines roaring 
“Band of brain smugglers arrested” or, still worse, “Sci-
entists uncovered as graverobbers”. Almost immediately 
we had several dozens of brains, and in 1987 we pub-
lished our combined neuropathological experience from 
100 AIDS autopsies, including most beautiful EM photo-
graphs of HIV virions provided by Silvia Cristina, a very 
gifted pathologist [10]. The next step was visualisation of 
HIV products in the brain, as I had done previously with 
other viral infections, and detailed determination of cell 
tropism in the brain [11]. As already suggested in my 
work on the multinucleated giant cells of HIV encephali-
tis, productive infection was seen exclusively in microglia 
and macrophages, a new paradigm of infection and 
inflammation in the brain, with neural elements proper 
not participating in virus replication and production. 
However, neurons are secondarily affected: in collabora-
tion with Prof. Haug’s neuroanatomy group in Lübeck, 
we demonstrated by morphometry neuronal loss in AIDS 
brains [12], in addition to HIV encephalitis and leu-
koencephalopathy another substrate of HIV-associated 
neurological disorders (HAND). 
A midlife crisis 
My career in neuropathology was successfully un-
der way when, almost exactly at midterm of my period 
in the NI and at the age of 44, the confidence in my fu-
ture was shattered. In 1990, I had two invitations for 
meetings in India, one to speak at the World Neurology 
Congress in New Delhi on HIV and the nervous system, 
and another to contribute to a specialised satellite sym-
posium on SSPE at the famous Christian Medical College 
in Vellore, a more than 100 years old foundation in a city 
in the South, originally for women only, with an affiliated 
hospital, by now one of the premier such institutions in 
India. Whenever participating at scientific meetings, I 
always try to squeeze off a few days for my own sight-
seeing, on and off the beaten track, in particular when it 
was the first time for me in that area. Then it was my 
first time in India, and I was shocked to verify myself the 
amount of poverty and suffering on the streets, with 
people lying and dying on crammed sidewalks in the 
North. To some contrast, the South seemed better off, 
with less pressure by sheer numbers of people and a 
friendly tropical climate. The meeting in Vellore was 
organised by Dr. Jacob John, already then an eminent 
virologist who fortunately makes his expert opinion still 
heard now on CoVID-19. I was much impressed, but still 
more when he took us foreign participants to the hospi-
tal ward to meet patients with infections in India. As 
neuropathologists, usually we do not see individual fates 
and histories behind our fascinating stains and slides; so 
first-hand experience by meeting patients with diseases 
of our study topics is a completely different dimension. 
They had several boys with SSPE in the ward, for most of 
us now an interesting but extremely rare if not exotic 
condition; however, I would wish that anti-
vaccinationists could see the devastating and deadly 
disease that is preventable by measles vaccination. Oth-
er interesting cases included what I discussed with Dr. 
John as Tropical Spastic Paraparesis, then a new retrovi-
rus-mediated disorder, tuberculoma and many unclear 
conditions. I became speechless seeing all that. Appar-
ently this experience well coincided with what was emo-
tionally my midlife crisis – I spent the following nights 
and days seriously considering to drop out of my safe 
harbour of academic work, career and family life and 
start again from scratch with clinical work in a place like 
Southern India, where your personal contribution to 
alleviate sufferings could really make a difference. I 
turned pros and cons in my mind, realising that the 
youngest of my kids was already 10 years old, so it 
would be not that damaging for their upbringing if I 
would leave, whereas their economic future might be-
come uncertain. The longer I pondered these considera-
tions, the paler the memory of South India became, and 
finally these ideas faded away. Apparently I had no guts 
for a complete new start, and it was much more conven-
ient to follow in the prepared footsteps of one’s com-
fortable life. Do I regret it? I am not sure, even now 
when I am very happy with my life track, and probably 
any present thoughts on what-would-have-been are 
more coquetry than deep-hearted wishes. 
National and international neuropa-
thology 
The 1990s were an important period for the old NI. 
After more than 100 years, its facilities moved in 1993 
from the old building at Schwarspanierstrasse to the 
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newly built university hospital, the New Allgemeines 
Krankenhaus (AKH) where NI was renamed as Clinical 
Institute of Neurology (KIN) and located in the ground 
floor at the southeast corner of the enormous main 
building. I had been involved in planning for the new 
location since more than a decade and was proud to 
have achieved a consented plan offering unique facilities 
for the future. The move itself was one of my worst 
experiences, and I commuted for weeks from the old to 
the new building. KIN was provided in the new quarters 
with generous space and top-class laboratories featuring 
most modern equipments for neuropathology (including 
an own EM and tissue culture), neurochemistry and 
molecular neurobiology. What was still missing I could 
manage to have added in later years, such as a dedicat-
ed prion BSL-3** lab, laser scanning and confocal micro-
scopes and laser microdissecting device. The downside 
was that the other multidisciplinary but non-clinical 
parts of the old NI were not transferred as well, but 
moved to a brand-new Institute of Brain Research in the 
completely refurbished building of the former Institute 
of Pathology, with Hans Lassmann appointed as Profes-
sor of Neuroimmunology and first Director. For the clini-
cally working parts of the old NI, now the KIN, the envi-
ronment of a modern university hospital turned out to 
be most beneficial, not only for diagnostic service, but 
also for research and teaching. After I became full pro-
fessor and Director of KIN, I followed the research out-
put by publications year by year, and from very modest 
scores in the early 1990s, a regular increase of cumula-
tive impact factors per year became evident, surpassing 
100 in the last years that I served as director until 2011. 
The move to the AKH was also favourable for 
teaching. Although NI had been involved in some practi-
cal courses to undergraduates, KIN became increasingly 
involved with teaching lessons for Clinics of Neurology, 
Psychiatry and the Institute of Pathology. Usually select-
ed topics of the neuropathological spectrum of diseases 
of the nervous system were lectured, but I always tried 
to include some of my very own concerns for future 
MDs. One general was functional neuroanatomy that I 
found rather underrepresented in students’ knowledge 
and understanding, and another specific was brain 
trauma, in particular by voluntary activities such as box-
ing, with the aim to inflict – or at least tolerate – brain 
damage to others, an issue that should prevent its per-
formance as sport. 
Such new success did not happen without shad-
ows. When describing above my early experience at a 
German congress in Poland with regard to a visit to 
Auschwitz, I mentioned also the need to clean up the 
institute’s backyard. It was only very late, around the 
turn of the millennium, that efforts were made by the 
University of Vienna and its Medical Faculty (from 2004 
the new Medical University of Vienna) to finally clarify, 
document and purge any remains of the Nazi past. For 
the institute, it turned out that the neuropathological 
archive contained brain samples, mostly processed his-
tological slides and blocks, of “handicapped” persons in 
mental institutions, mostly kids, who had been mur-
dered within the Nazi “Euthanasia” Program. In Vienna, 
the psychiatric institution “Am Spiegelgrund” was the 
place where these killings occurred, and brains of victims 
were collected and neuropathologically examined – later 
unbelievably supported by public funds – by Heinrich 
Gross who had also a role in the killings. For further 
research, some samples were later brought by Gross to 
the NI, and much later I had to identify and de-archive 
such specimens that were then ceremoniously laid to 
rest in a dedicated memorial tomb at the Vienna Central 
Cemetery. Additional data by Jürgen Peiffer from Tü-
bingen revealed that brains with a peculiar neuropatho-
logical disease from three brothers, murdered in the 
Landesanstalt Görden in Brandenburg, Germany, were 
first described by Franz Seitelberger as connatal type of 
Pelizaeus-Merzbacher disease (known today to be due 
to missense mutations in the PLP1 gene) in his thesis for 
habilitation. The samples had originally been archived in 
the Max-Planck-Institute for Brain Research in Gießen, 
Germany, headed by Julius Hallervorden who had been 
heavily involved in the neuropathological work-up of 
brains of victims of Nazi “Euthanasia”. Seitelberger had 
spent a postdoc stint in Gießen and brought these sam-
ples to Vienna and the NI. Again, I identified these sam-
ples in the archive and sent them to Hamburg where 
they were ceremoniously laid to final rest. 
As a small discipline, neuropathology relies very 
much on international contacts, interdisciplinary discus-
sions, connections with colleagues and friends, and 
communication at meetings. Having realised this soon, I 
have fostered such contacts by personal visits, invita-
tions and correspondence. In addition to diagnostic 
matters, it was research that was, and still is, most in 
need of international networking. An overlapping field 
encompassing both diagnostic work and research like 
neuropathology has classification of disease as a neces-
sary but also possibly arbitrary component of biomedical 
science and practice. Nowhere this was more evident 
than in the field of pathology of tumours of the nervous 
system that has been based on histogenetic concepts 
since long but clouded by complexity over generations. 
During medical studies, most of my colleagues just 
skipped the several pages of brain tumour types in our 
learning documents, as the classification given there was 
considered counterintuitive, intricate, confusing in plac-
es and simply too cumbersome to absorb. This fact has 
been recognised by the WHO that reacted by publication 
of the Blue Book series on tumour pathology. The 1st 
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Blue Book on “Histological Typing of Tumours of the 
Central Nervous System” was edited in 1979 by Klaus 
Joachim Zülch, an eminent neurologist-neuropathologist 
in Cologne-Merheim, and appeared, at least to outsid-
ers, as compromise between Zülch’s classical German 
tradition of neuropathology and the Anglo-American 
school represented by Lucien Rubinstein. As example, it 
included the monstrocellular sarcoma, one of Zülch’s 
dearest entities as sarcoma because of a distinctive 
network of reticulin fibres, as well as the monstrocellular 
glioblastoma championed by Rubinstein because of 
GFAP immunopositivity, both the very same tumour 
type. Thus most of the complexity remained. As I had to 
diagnose large numbers of neurosurgical biopsies, I ap-
plied my immunohistochemical expertise from my stud-
ies on viruses to CNS tumours and always tried to keep 
abreast of current trends. 
Much credit is due to Paul Kleihues, then Professor 
of Neuropathology in Zurich, to make an effort to renew 
brain tumour classification in a modern system that took 
account of molecular and genetic characteristics and did 
not only rely on morphology. A meeting was convened in 
Zurich in 1990, with 26 distinguished experts in neu-
rooncological pathology, almost all male, including me, 
and only two renowned female researchers, Lucy B. 
Rorke and Ana Lia Taratuto. One giant was notably miss-
ing – Lucien Rubinstein had died from brain haemor-
rhage briefly before. The result of intense deliberations 
– to include new entities, in particular the concept of 
primitive neuroectodermal tumour (PNET), and delete 
obsolete ones like the monstrocellular sarcoma – was 
finally published in 1993 as 2nd edition of the Blue book. 
The 3rd edition in 1997 and its update of 2000 followed 
meetings in Lyon in 1997 and 1999, were re-titled as 
“Pathology and Genetics of Tumours of the Nervous 
System”, had expansion on genetics and were published 
by the International Society of Neuropathology (ISN) 
together with the International Agency for Research on 
Cancer (IARC) that was then directed by Paul Kleihues. 
The 4th edition in 2007 and its revision in 2016 returned 
to the title “WHO Classification of Tumours of the Cen-
tral Nervous System” of the old Blue Books. All these 
editions proved to be an indispensable tool for neuropa-
thologists not only in their daily diagnostic work, but also 
in use of a common language with clinical colleagues and 
basic researchers. I have contributed to all editions and 
was mostly happy with the outcome, with one excep-
tion: I remained sceptical about the scientific rigour and 
value of the WHO grading system that applied four uni-
form prognostic categories across all types of tumours 
and was carried on unchanged since the very start in 
1979. We had heated discussions at all meetings on that 
issue, but Paul was a passionate and dominant defender 
of WHO grading. Moreover, he was clever enough to put 
discussions on this topic to the very end of the agenda – 
usually there was not enough time left for debates in 
depth. 
Based on my experience with tumour neuropa-
thology, I realised the importance of working with estab-
lished national and international bodies with regard to 
diagnostic matters, research and fostering of the disci-
pline. Thus I have served for several periods as President 
of the Austrian Society of Neuropathology. In Europe, 
the supranational European Confederation of Neuropa-
thological Societies (Euro-CNS) is the contact for profes-
sional matters, and I became president in the early 
2000s. The International Society of Neuropathology (ISN) 
is the global representative of our discipline, and I have 
served as national Councillor, as Vice-President and 
finally as President from 2010 to 2014. Many scientists 
have disgust for such officer honours and “committolo-
gy” in general, as they feel it much more rewarding to 
spend time in the lab than in discussions at formal ad-
ministrative meetings. Indeed, such meetings may pro-
duce little more than hot air, but my experience tells it 
depends on you – yes, on you in whatever function you 
attend – how productive or not your participation will 
be. Moreover, don't forget: If you don’t commit yourself 
to meetings, there is always a possibility of non-
transparent agreements negotiated in back rooms by 
parties attempting to over-rule others, something no-
body wishes (or claims so…). 
The prion decades 
In the early 1990s, I realised that the type of HIV 
neuropathological studies, as I had done for almost a 
decade, was unlikely to contribute much novelty to our 
future understanding. So where to look next? In the field 
of infections, a new paradigm was emerging that over-
lapped with neurodegeneration – something called pri-
on, an infectious proteinaceous particle, a name coined 
by the later Nobel laureate Stan Prusiner for agents 
causing transmissible spongiform encephalopathies, 
then still hotly debated and regarded by many as viruses 
or virus-like agents. In Austria, we had a disease dubbed 
as “Austrian Kuru” by Franz Seitelberger who studied the 
neuropathology of several cases of a family condition 
first described by Josef Gerstmann, Ernst Sträussler and 
I. Scheinker in 1936, now usually abbreviated as GSS. 
Scheinker's first name initial would mean Isaac, as I 
found out, a name not appropriate in Germany under 
Nazi rule. Featuring prominent amyloid plaques, the 
pathology indeed resembled that of Kuru, the New Pa-
puan disease that D. Carleton Gajdusek transmitted to 
chimpanzees, like he did later also with Creutzfeldt-
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Jakob disease (CJD). Again, I stepped into that research 
field more or less by chance – or by another good luck? 
Fortunately, I had some reputation with the then 
professor of neurology in the university hospital Vienna, 
Herbert Reisner. He sometimes called for my opinion 
when he suspected strange and rare clinical cases. As 
example, I could diagnose the first clinical case of pro-
gressive supranuclear palsy, a disease then practically 
unheard of by clinicians in Vienna. Once he even took 
me as company when he got a call from the Veterinary 
University to consult on a horse with a strange gait dis-
order. We came to the stable holding the horse, to have 
a look how the animal moved. The horse was there, but 
Prof. Reisner not – he had immediately hidden behind 
the door and told me to examine the horse in his ab-
sence. I learnt later that, possibly as sequel of war trau-
ma, he hated horses and was terrified by them. The 
horse suffered from what veterinarians called a “wob-
bler”, a yet rather unspecified ataxic condition, and I had 
to decide myself what to recommend. Guess what my, a 
neuropathologist’s, recommendation was? Euthanasia 
and neuropathological examination to get a final diagno-
sis, something that turned out not to be feasible be-
cause of severe squeezing artefactual damage of the 
thick equine spinal cord when the mortuary assistants 
pulled it out like a rope. 
In 1990 Prof. Reisner asked me for an opinion on a 
rare case that some considered as CJD. The middle-aged 
lady had indeed symptoms and signs indicative of CJD, 
but additional spinal long tract signs were unusual, and I 
had a yet unspecified feeling of something very special. 
Normally, I never think of it, but here I looked for the 
maiden name of the patient. Bingo! It was “H”, the name 
of a family that I knew very well from earlier studies of 
important cases in the archive of the NI – I had discov-
ered a new case of the original Austrian GSS kindred! It 
had been completely lost to follow up since some 30 
years, as family members were dissatisfied by their ex-
perience with medical doctors who were unable to help 
them; some even told them to belong to a “syphilitic 
family”, since spinal long tract signs are characteristic of 
Tabes dorsalis. In the small villages south of Vienna 
where most of the family lived, this was not something 
to like to hear or speak about. Anyway, the re-discovery 
enabled us to complete the full pedigree to 221 mem-
bers in nine generations from the late 18th century on-
ward, with at least 20 patients suffering from definite 
GSS, our last proposita presenting a switch from classical 
GSS to a CJD-like phenotype [13]. We tried over the 
following years to find out why and how a disease with 
the very same genetic aberration in the same family was 
able to change the phenotype, but this has remained 
elusive. Anyway, it was reassuring to find the salient 
P102L mutation in the prion protein gene PRNP also in 
the original GSS family, in collaboration with Hans 
Kretzschmar from Munich [14]. 
From 1994 onwards, initially well before the ad-
vent of variant CJD (vCJD), I succeeded in coordinating a 
series of large European networking projects funded by 
the European Commission (EC). The aim was to establish 
and apply diagnostic criteria in the neuropathological 
assessment of human prion disease, to determine their 
clinicopathological phenotypic spectrum and work on 
specific research issue related to tissue pathology. These 
projects perfectly complemented other EC projects co-
ordinated by Bob Will from Edinburgh on clinical surveil-
lance of human prion diseases. It was a pleasure and 
privilege to collaborate with Bob for many years on 
these challenging issues, and to make many good friends 
in the prion surveillance system, including Heino Dir-
inger, Paul Brown, James Ironside, Maurizio Pocchiari, 
Fabrizio Tagliavini, Inga Zerr, Pawel Liberski…. The scien-
tific collaboration within such networks was strength-
ened by meetings at regular intervals; my own EC pro-
jects had their meetings usually in the small town of 
Baden near Vienna, a historical spa type of place popular 
already in the Austro-Hungarian Empire. The huge bonus 
of these meetings were the limited number of partici-
pants (usually between 50 and 100), lectures on timely 
and emerging prion issues by top researchers followed 
by enough time for detailed discussions, and half a day 
reserved for socialising, walking and hiking. Following 
these simple rules, these meetings have become almost 
legendary in retrospect – whenever I meet people who 
had attended, it becomes a nostalgic exchange of mem-
ories. Baden is amidst a wonderful, wine-growing land-
scape at the very Eastern end of the Alps, where pleas-
ant hills of the Viennese Woods come down to the Pan-
nonian planes, so hiking there was always a most enjoy-
able activity – and sometimes a true escapade to re-
member. 
As the Baden area was not too familiar to me and 
we had to keep our time schedule, I wanted somebody 
to guide us on our hiking tours. I have a friend who lives 
in the area, Erich, a retired high school teacher who 
described himself as knowing every rock in the vicinity 
and was enthusiastic to take over the organisation and 
guidance of our hike. It was an unusually hot day in early 
June, and the first part of the track was steeply uphill for 
about 45 minutes. Erich calmed down early wishes for a 
break by promising a mountain lodge on top. When we 
arrived, thirst was significant, as was disappointment: 
the lodge was closed for restauration. No problem for 
Erich: as he knew all hidden details of that part of the 
forest, he promised to get us to a spring with wonderful 
fresh water. Of course, in order to get there, we had to 
leave the marked trail and step into the dark forest. I 
had advised everybody in the 40-plus-numbering group 
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of hikers to wear strong walking shoes, but some ladies 
apparently misunderstood that as invitation to test the 
most modern and glitzy slippers then available. As to 
expect, it was not that easy for such a poorly equipped 
party to walk across thickly covered forest floor. Finally 
arriving exhausted at the spring, another disappoint-
ment and still more reason for thirst: the spring had 
dried up, and Erich had some trouble to explain why he 
had not been aware of an unusually prolonged dry peri-
od in the immediate past. Feelings of despair were pal-
pable, and I decided in a revolutionary mood to take 
command. I phoned our bus driver, ordered him to buy a 
supply of boxes with hectolitres of water bottles and 
come to the nearest parking spot where a bus could go. 
It was still some more 45 minutes to walk there, but 
fortunately downhill below shady trees, so a full rebel-
lion by the party could be avoided by repeated an-
nouncements how near the bus parking already was. 
When we arrived at the bus, exsiccated and with ragged 
clothes, everybody offered a fortune for a drop of water. 
I threw away my chances to get such a fortune, like al-
ways, and gave the water for free. Finally, whatever 
worries people had, they disappeared suddenly and 
were replaced by everlasting memories of an exciting 
adventure. 
The work on human prion diseases coincided with 
emergence since the late 1980s of a new animal disease, 
bovine spongiform encephalopathy (BSE), aka mad cow 
disease. Hundreds of thousands of bovines were affect-
ed, had to be slaughtered and disposed of in the UK. This 
economic disaster accompanied loss of public confi-
dence in politics, a phenomenon that spilled over also to 
continental Europe where BSE became a problem only 
delayed, from around 2000. In 1996, the high water 
mark broke when UK government officials had to con-
cede that BSE had transmitted to humans in form of 
another new disease, variant CJD (vCJD). Proof for that, 
of course, came by neuropathology: James Ironside in 
Bob Will’s group demonstrated characteristics of a new 
prion neuropathology. Immediately, some hysterical 
press releases forecasted an armageddon of millions of 
victims, and feverishly reactions and solutions were 
deliberated, in the UK as well as in the European Union 
(EU). This was the hour of experts – however, at the 
time few were there, as prion diseases had been the 
domain of a small group of basic researchers in biochem-
istry, of veterinarians working on scrapie, the prototype 
prion disease in small ruminants, and of medical special-
ists in epidemiology, neurology and – you are right again 
in guessing – neuropathology. Surveillance for human 
prion diseases became quickly established throughout 
Europe and needed neurologists, laboratory specialists 
and neuropathologists. In Austria, the Austrian Refer-
ence Centre for Human Prion Diseases (ÖRPE) was for-
mally established at the NI and funded by the Ministry of 
Health. ÖRPE served as national focal point as well as 
representative for international contacts in the quickly 
enlarging prion arena. I was head of ÖRPE from 1996 
until 2012 when I left to work in Zurich. 
At the time of the BSE/vCJD meltdown, the top sci-
entific advisory body in the EU was the Scientific Steer-
ing Committee (SSC) that quickly established its own 
prion advisory panel, the TSE/BSE Ad Hoc Group with 
about 20 members with experience in all aspects of 
these diseases. I had the privilege to be chosen as mem-
ber, and from 1997 we had meetings in Brussels every 
month or even more often. For preparation of these 
meetings we were sent exhaustive documents, some-
times numbering hundreds of pages. The pressure was 
considerable, but the panel was highly successful to 
recommend a series of comprehensive measures to 
mitigate the risk, most notably with regard to the safety 
of animal-derived products, identification for destruc-
tion of specified risk materials in the food and feed 
chains, quantification of the residual BSE risk in food, 
and country-wise evaluation of the geographical BSE risk 
according to a standardised set of parameters [15]. It 
was a most interesting experience, as everything had not 
only public health and economic, but also political impli-
cations. In contrast to some members of the SSC, the 
TSE/BSE Ad Hoc Group appeared to me more reluctant 
and cautious, and in the group I worked most closely 
with Dominique Dormont and Hans Kretzschmar. They 
were not only wonderful scientists and friends, but had 
the very same cautious approach to a situation with 
many unknowns. We even insisted on a minority report 
when we disagreed with the SSC on a pivotal issue. Now, 
years after they have died, I still miss them. 
When it became clear in 2000 that BSE was present 
in continental Europe, we also had in Austria our first 
BSE cases that put the government into a panic-stricken 
work mode. Restaurants in Vienna were particularly 
affected by the BSE crisis, as boiled beef from Tafelspitz, 
a peculiar meat cut, is a traditional delicacy that, as the 
saying goes, was never missing at Francis Joseph’s impe-
rial table.* For a few weeks, I was interviewed many 
times by TV and radio, and in the midst of this turmoil I 
got a phone call from a governmental secretary to invite 
me to a “beef dinner” with the Austrian Federal Chancel-
lor, the head of government, the Federal Minster of 
Agriculture – and me. Although having never been a 
member of a political party or movement, I smelled that 
 
* Note to gourmets: my personal preference is not the famous 
Tafelspitz that I find too dry, but some cuts with slightly fatter compo-
sition like Schulterscherzel or really fat Beinfleisch, or Kruspelspitz with 
a small cartilage. This must be served within a beef broth garnished 
with slices of bone marrow tasting like paradise on toasted dark bread. 
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the aim was to stage a televised public event at which 
the safety of Austrian beef should be verified beyond 
doubts by shared politico-scientific consumption of 
Tafelspitz. I respectfully declined the invitation and ex-
plained that I loved boiled beef but that I was in science 
and medicine but not in political activism. Retrospective-
ly, some might argue that I missed a chance to climb up 
the career ladder, but I was happy with what I got – and 
then indeed did not rise higher. 
After 2003, scientific advice and risk assessments 
were continued by the newly established European Food 
Safety Authority (EFSA); prion-related issues were han-
dled by its Biohazard Panel. Again, I became a member, 
later its vice-chairman, until 2012. Monthly two-day 
meetings were held, at first in Brussels and, after com-
pletion of the new EFSA headquarters, in Parma, Italy. 
Numerous opinions on various aspects of food safety 
were the outcome of our work there. With regard to 
BSE, vCJD and other human prion diseases, it became 
clear that scientific advice on risk mitigation has resulted 
in almost complete disappearance of classical BSE, a real 
success story, whereas other prion problems persist 
[16]. 
During the long years with EFSA the beautiful and 
historical city of Parma became dear to me, as did the 
colleagues in the panel – it was a constructive and open 
atmosphere that I enjoyed very much. As Parma is the 
very food capital of Italy, we had of course splendid 
dinners there. My favourite was il bollito misto de Par-
ma, a famous dish with meats from cheek, tongue, tail, 
belly and head, mostly beef, some stuffed but all just 
boiled, sounding like components of Scottish haggis, but 
reminding me more of the typical Viennese Tafelspitz. As 
the Habsburgs used to export princesses as monarchic 
wives all over Europe, Maria Luisa, the daughter of Aus-
trian emperor Francis II, who had been Napoleon’s sec-
ond wife and thus Empress of France, was later made 
duchess of Parma. Maria Luisa had great impact on Par-
ma, and there are still Austrian souvenirs in Parma, with 
the bollito probably as one of the most prominent. Upon 
request, I can advise on the best ristorante for bollito. 
Success and recognition 
How do you measure success in science? Depends. 
As always, money counts also in research, no question. 
Thus it is essential, already early in a career, to acquire 
research funds from whatever source possible, some-
thing that needs to be trained, as amounts of funds 
collected for research, patents etc. have become one 
hard currency of measuring success in science. The other 
is publications; there are now bibliometric parameters 
that determine work, career and even the very existence 
of scientists. This can be considered good or bad, but it 
definitely is not all what counts. In the present world of 
multi-authorships, sometimes diluted up to 100 co-
authors or more, I am proud to have been one of the 
very few who wrote many articles as single author, 
without the safety net of helping hands. Of course, this 
has become different nowadays – present science by 
necessity has become teamwork, even a world-spanning 
network. Another aspect is the range of research, 
whether it is narrow and limited to a single problem or 
wider. For an academic career – and I have witnessed 
that from sitting on a plethora of search committees for 
academic positions – it is important to prove both depth 
and breadth in research. As a now almost extinct species 
in this regard, I am also proud of having published in 
virtually every field of the discipline, from developmen-
tal neuropathology over metabolic and toxic, inflamma-
tory, infectious and vascular diseases to neurodegenera-
tion, tumours and neuromuscular disorders. Many pa-
pers have been highly cited, and I have achieved a high 
Hirsch index – the beauty with that, in my view, is its 
steady growing, even when you publish little at present, 
as I do. However, what is really important is to have 
made new contributions to the general body of 
knowledge, such as I did with first observations or con-
ceptual outlines, as our report in collaboration with Kenji 
Kosaka about a case series with neocortical Lewy bodies 
characterising a new disease, now called Lewy body 
dementia [17]; or neuropathological diagnostic criteria 
for CJD [18], neuropathological features [19] and other 
aspects of prion diseases [13, 14 and many others] in-
cluding the subcellular localisation of disease-associated 
prion protein [20] and characterisation of a new disease 
in wild-type animals by synthetic prions [21]; the neuro-
pathology of HIV infection [10, 22 and many others], 
viral products in tick-borne encephalitis [23]; GFAP in 
oligodendrogliomas [24], the clinical relevance of men-
ingioma subtypes [25]; a new glial globular tauopathy 
[26], nigral burden of α–synuclein as a correlate of stria-
tal dopamine deficit in Parkinson’s disease [27], morpho-
logical evidence of α–synuclein propagation in the hu-
man brain [28], the basis of biomarker diagnostics in 
neurodegeneration [29], the frequent mixture of neuro-
degenerative pathologies in the aging community [30], 
and transmission of Aβ by dural grafting [31]. 
After transfer of the old NI into the AKH, we estab-
lished several clinical routine processes to support our 
daily work in an expanded environment, such as weekly 
conferences with the whole staff, research reporting 
meetings and time-fixed daily microscoping sessions 
around a multi-ocular device that was able to accommo-
date up to 10 viewers (Fig. 7). It was where we had most 
of our diagnostic and scientific discussions, in particular 
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Fig. 7. Daily microscoping sessions were always held around the multi-head viewing microscope, here in the second half of the 1990s 
when an old and cherished friend and neuropathological giant, John Kepes with wife (in foreground) was visiting from Kansas City. 
Sitting behind them, Haberler at left and Budka at right, standing from left, Hainfellner, Hussun (a pathologist from Yemen), Jarius, 
Wanschitz. John had briefly stayed at the NI after the failed Hungarian revolution of 1956. 
 
when we welcomed distinguished visitors such as John J. 
Kepes (Fig. 7) or Bob D. Terry (Fig. 8). And it was always 
fun and a pleasure, as well as a place where to preserve 
the good working atmosphere. 
In the early 2000s, a young clinical neurologist ar-
rived from Budapest, Gabor G. Kovacs, to learn some 
neuropathology. His boss at Semmelweis University, 
Prof. Szirmai who had stayed as postdoc at the NI two 
decades before, was reluctant to let him go. Soon I 
found out why: Gabor became the very best trainee I 
ever had, with an unbelievable eye for morphology, a 
sound biological understanding and intelligent transla-
tion of neuropathological features into clinical signifi-
cance, extreme diligence and last but not least, in 
agreement with Albert Einstein’s dictum that it is charac-
ter that makes the scientist excellent, an open, warm-
hearted nature that made him soon everybody’s darling 
at the institute. It was Gabor who soon covered most of 
the research work, most prominently in the prion field 
but also elsewhere in his broad interests. It is sad for me 
to realise that he left – in my belief was forced to leave 
because of the circumstances – two years ago to be-
come full professor in Toronto, Canada, a brain-drain 
consequence of the turmoils suffered by the institute in 
recent years, but definitely a deserved recognition for 
this fine man and scientist. 
In the years of my directorship, I was indeed lucky 
to have an excellent staff that was about equally bal-
anced between neuropathology and neurochemistry 
(Fig. 9). Around the same time when Gabor arrived, Ellen 
Gelpi, another young researcher, joined from Barcelona. 
With her warm-hearted Mediterranean-style approach 
to all matters, irrespective of how important or not they 
were, she soon became an indispensable hand in diag-
nosis and research, from prion diseases to tick-borne 
encephalitis. We lost her for some years to an attractive 
position as head of a Brain Bank in her home city, but 
fortunately she is now back and remains the very soul of 
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Fig. 8. Bob Terry, another giant of neuropathology, with the 
author at an Alzheimer conference in Southern Styria, a wine-
growing region, Nov. 2007. Kurt Jellinger in the centre at back. 
the institute. Another indispensable mind and soul is 
Romana Höftberger who trained with Hans Lassmann in 
neuroimmunology in Vienna, and with Josep Dalmau and 
Francesc Graus in Barcelona. She has high reputation in 
research on antibody-mediated disorders of the CNS, 
actually relevant for both neuropathology and neuro-
chemistry, and thus is now the no-longer-missing-link 
between the two major areas of work in the institute. 
Last but not least, Christine Haberler has made her name 
known in the field of paediatric tumour neuropathology, 
something that needs very specialised expertise. For me, 
aging as an “old white man”, it was a pleasure to see a 
highly successful female touch in achieving the most 
recent accomplishments of the institute. 
With increasing age, and success of KIN in general, 
I was awarded some prizes that recognised our work in 
some specific areas. Already as far back as 1982, I had 
received the Moore Award for the best paper on clinico-
pathological correlation at the American Association of 
Neuropathologists (AANP) meeting; it was for my work 
on IHC in PML, and I was proud of it because I received 
the award despite the session chairman’s attempts to 
disturb my presentation. He insisted to limit the number 
of slides at my talk; so this was a very distinguished vi-
rologist who arbitrarily decided that a youngster had 
two slides too many than what he personally considered 
appropriate. No, Sir, I explained politely but firmly to 
him that I would definitely show all my slides, that num-
bers of slides don’t matter as long the allotted time 
frame is kept, but that he could, of course, stop me if I 
would go overtime. So good arguments do help young-
sters against forceful professors. 
 
 
Fig. 9. The KIN staff in 2006. 1st row, from left: Hainfellner, Regelsberger, Budka, Ströbel, Gelpi, Pipp, Haberler, Höftberger, Bernheimer, 
Trabattoni, Preusser; behind, the dedicated laboratory and secretariat staff committed to the success of the institute. 
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Fig. 10. Lecture at the award ceremony to receive the Dorothy 
S. Russel Prize by the British Society of Neuropathology in 
London 2008, in front of a memorizing image of my all-time 
hero, Lucien J. Rubinstein (photo courtesy of BNS). 
For explanation of the then highly publicised BSE 
and prion situation, I frequently gave scientific state-
ments to the public by press, TV and radio. These were  
obviously well received, as I was awarded with the title 
of “Austrian Scientist of the year 1998”; the prize includ-
ed also the naming of a star after the awardee in one of 
the far corners of the universe. In 2004 I received an 
honorary doctorate from the Medical Academy Łodz in 
Poland, and in 2008 I had the honour to give the Dorothy 
Russell Memorial Lecture at the British Neuropathologi-
cal Society Meeting in London (Fig. 10). 
 
Fig. 11. Since about 2010, KIN participated in the “Children’s 
University” with demonstrations of brain anatomy to primary 
schoolchildren. All are exited to see a real brain – some even 
do not dare to look. 
In 2007, we celebrated the 125th anniversary of the 
Institute by a dedicated symposium [32]. Many friends, 
including some from overseas, came to follow a series of 
lectures and posters on NI/KIN’s history and our more 
recent achievements. It appeared then that the future of 
KIN was safe and expected to prosper, and I even specu-
lated whether I would live to see the Institute’s 150th 
anniversary in 2032. 
One of my concerns was to maintain and foster a 
good relation to the non-medical and non-scientific 
world that is funding everything we do. One possibility 
was the Children’s University when kids who visited KIN 
were told about our work and, most importantly, even 
could touch a human brain if they dared to (Fig. 11). 
The third family 
 
Fig. 12. The family in Dec. 2019 at a dog exhibition when Gorry 
became Austrian Junior Champion. 
I met my second wife Ivana in 2003 by chance, dur-
ing a summer most Europeans probably remember, as it 
was extremely hot and beautiful. After my divorce I used 
weekends and holidays to make long trips by bike (or by 
car when it was too hot) and stop in between for a re-
freshing swim, once even in the big Danube river when a 
most beautiful young lady caught my eyes. I was imme-
diately hooked. She is Czech, worked as a nurse in mo-
bile care in an area northwest of Vienna, and then took a 
dip in between like I did. She soon decided to take a job 
offer in a big municipal hospital in the post-surgery re-
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covery room according to her training in anaesthesia. 
Our daughter Natalia was born in 2007, and this time 
circumstances were much more family-friendly than 
with my earlier family. I had more time to spend with 
the family, of course never enough in a job such as mine, 
and it was – and is – an absolute delight to see Natalia 
growing up. When I went to work in Zurich, Ivana want-
ed to accompany me with Natalia, but I was unsure how 
it would work out in a completely different setting, with 
a foreseeable deadline and much higher costs for school-
ing and living than in Vienna. So we arranged that the 
family would stay in Vienna, and in the “guest-worker” 
tradition of Europe I would live over the week in Switzer-
land, with commuting flights every Friday afternoon to 
Vienna, and early Monday morning from Vienna. After I 
came back from Zurich at the end of 2016, I had of 
course plenty of time to spend with the family. Ivana 
was ambitious to do a master’s study of three years and 
is now a recognised specialist for pain nursing. Two 
years ago we gave in to Natalia’s dearest wish, and Gorry 
joined our family, a female Portuguese water dog, which 
is admired not only by us, but also by practically every-
body we meet when walking her (Fig. 12). 
Zurich 
At an age of 65, I felt too active to do little to noth-
ing after retirement in Vienna, so I looked elsewhere and 
found an announcement for a position of consultant at 
the Institute of Neuropathology of the University Hospi-
tal Zurich, headed by Prof. Adriano Aguzzi. I knew Adri-
ano from several meetings, as he is a renowned prion 
researcher. Adriano was delighted when I phoned him, 
and we quickly agreed on my start in Zurich from May 
2012. I commuted between Vienna and Zurich by flights 
on Mondays and Fridays, almost always with the same 
bunch of expats in the plane. I tried a few times to drive 
by car, but it is some 750 km and more than 7 hours 
driving time, a rather exhausting adventure. I lived for 
my first two years in a hostel tower for university visi-
tors, students and postdocs, high enough to have a spec-
tacular panoramic view of the city, before renting a 
small apartment near the Limmat river. It was wonderful 
to walk every morning from there alongside the river to 
the hospital and back in the evening, watching a lot of 
waterbirds like cranes, encountering youngsters jumping 
into the water or balancing on slacklines, and passing by 
still existing public river baths made entirely of wood, 
cherished by the locals as “Badis”. In comparison with 
Vienna, Zurich has a well preserved medieval centre, but 
is much smaller, much is within walking or biking dis-
tance (Adriano turned out to be a passionate mountain 
biker daily climbing up the Ütliberg overlooking the city), 
the river is in the very centre, and the lakeside part of 
town has an almost Mediterranean feeling. So it is a 
gorgeous place to live indeed. 
I must admit that I came to Switzerland with some 
trepidation, as I was unsure how the relation with Adri-
ano, who was well known as strong personality, would 
work out. In fact, it turned out to be an extremely pleas-
ant and convenient situation: since an eternity, I had 
suddenly no or few administrative duties but could con-
centrate on what I like most (and probably do best), 
studying and diagnosing interesting neuropathological 
cases. As Adriano was busy with his big experimental lab 
that comprised some 30-plus postdocs and graduate 
students in addition to a basic staff of researchers and 
technicians, he was happy to leave the clinical diagnostic 
service to me and Elisabeth Rushing, a very friendly and 
easygoing colleague and most experienced neuropa-
thologist with whom it was a delight to harmoniously 
share supervision of a young team of motivated and 
gifted trainees. Elisabeth had specialised in tumour and 
muscle neuropathology and had been the last head of 
neuropathology at the legendary Armed Forces Institute 
of Pathology (AFIP) in Washington, DC, before its closure 
in 2011. Together with Adriano, I was also responsible 
for the Swiss National Reference Centre for Human Prion 
Diseases (NRPE). Overall, my time in Zurich was the very 
best indeed that could happen to an aging guy at the 
end of his career. I am most grateful to Adriano – who 
might have had also some trepidation at start, as I have 
been considered by some as strong personality as well – 
to have given me such an opportunity. I learnt a lot 
there, most notably in experimental neuropathology 
where I had little experience, but also how to organise 
and run a successful institute in a way differing from 
what I was used to do. In fact, after passing the age of 
70, it was with a heavy heart that I had to stop my stint 
in Zurich. 
Retirement and Aftermath 
For a long time, I thought that formal retirement in 
Vienna, due for Oct 1st, 2011 (Fig. 13), was still a long 
shot in the future. Big error, it came quicker than I had 
imagined. I had made some plans that would be options 
for that remote time, but in fact, believe it or not, it took 
me almost by surprise. Somehow lost, I suddenly had to 
look for attractive possibilities to continue at least some 
of my activities. So I made a visit as honorary professor 
to the Naval General Hospital in Beijing, on invitation by 
Prof. Xiaokun Qi, a neurologist with keen interest in 
neuropathology. In addition, I visited the Brain Bank, 
Karolinska Institutet, Huddinge Hospital, Stockholm, 
Sweden, as Guest Consultant for several times, on invita-
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tion by Prof. Bengt Winblad, Caroline Graff and Inger 
Nennesmo, the local neuropathologist. 
However, I hoped most to be able to contribute in 
some function for KIN in the future. For a few months I 
was given a room that was soon converted into a secre-
tariat, and I could keep only a desk elsewhere that, 
again, was taken away after a short time. After these 
disappointments, I looked for something else and found 
the position in Zurich described above. 
 
Fig. 13. Commemorating plaque given to me by the KIN per-
sonnel at my farewell party in 2011. It is in the style of a shop 
sign in the Habsburg tradition. Its text means “Highly laudable 
neuropathologist in non-retirement”. 
After coming back to Vienna from 2017, I contin-
ued to work on a few forensic cases every year, giving 
detailed reports to state attorneys and courts, a good 
possibility to keep active and in touch with neuropathol-
ogy. Of course the number of my publications has dwin-
dled down, and at the end of my scientific career I came 
back to my neuropathological love affair, viruses: most 
recently, I wrote a chapter on flaviviruses and tick-borne 
encephalitis (TBE) in an ISN-sponsored book on infec-
tions of the nervous system [33]. In view of the present 
unique global challenge by SARS-CoV2, I hope to be able 
still to contribute my experience with neuroviral pathol-
ogy to research on CoVID-19. 
With regard to the future of KIN, I expected that a 
search committee would be appointed soon after my 
retirement by the Rector and Senate of the Medical 
University Vienna, to fill the vacant position of full Pro-
fessor of Neuropathology and Institute Director. Such a 
committee is common practice in most if not all universi-
ties when a professor retires, and its aim is to find the 
best candidate; my personal favourite was Gabor, of 
course. For unclear reasons – at least for me – this did 
not happen, and year by year went by while I was in 
Zurich. My former deputy, Hans Hainfellner, was keen to 
head the institute but remained formally only deputy 
director until 2019 when, till the end of that year, the 
Director of the Institute of Pathology was intermittently 
appointed to head KIN. Reasons to appoint an external 
Director were, as I was told, financial frictions between 
the Medical University Vienna (MUV) and AKH about 
charging for KIN diagnostic services; in a hybrid fashion, 
KIN has been funded by both MUV and AKH. Finally and 
sadly, it was decided to formally degrade the traditional-
ly independent institute on Jan. 1st, 2020, after a highly 
successful history of 137 years, to a Division of Neuropa-
thology and Neurochemistry of the Neurological Clinic, 
as a MUV-only organisational unit. This was only the 
second best option to avoid the worst, i.e. complete 
disbanding when neuropathology would become part of 
pathology, and neurochemistry would be incorporated 
into laboratory medicine. Why the by far very best op-
tion was not pursued, i.e. the further existence of such a 
renowned and successful institution, has remained a 
mystery, not only for me, but also for other MUV profes-
sors. Fortunately Romana Höftberger, an associate pro-
fessor of KIN with excellent knowledge of both neuropa-
thology and neurochemistry, was made head of the new 
Division; I am sure she will do her best to steer it into 
calm waters. Similarly, Prof. Thomas Berger, the Director 
of the Neurological Clinic and now responsible for the 
old institute becoming new Division, promises to keep it 
alive as much as possible. 
Epilogue 
At the end, it is time to balance. Was all indeed as 
positive as these reflections appear, or is it just due to an 
extended version of the reminiscence bump? For my 
professional and family lives, there is definitely nothing 
to regret. With regard to the role of my beloved neuro-
pathology, I cannot find a better summary definition 
than what Lucien Rubinstein wrote: “It is that neuropa-
thology is an exquisitely enjoyable pursuit”. The only 
bitter pill, however, is my personal finale – I never 
dreamed of becoming the very last director of the origi-
nal institution that has shaped my whole life. 
What about the future? For a long time, I used to 
give a special farewell gift to postdocs and graduate 
students who trained with me, Santiago Ramón y Cajal’s 
“Advice to a Young Investigator”. It is an interesting and 
amusing reading, not only because he was one of the 
most eminent neuroscientists in history, but also be-
cause his advice penetrates virtually every relevant issue 
of life. A hilarious example is Cajal’s criteria for selecting 
the best wife for a scientist: she should be unattractive, 
because otherwise she would be too distractive, and she 
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should be rich, to make the husband financially inde-
pendent in his research. I don’t have such down to earth 
advice (and I did not follow that advice). However, I 
believe in an attitude that seems to imbibe also Ramón y 
Cajal’s writing and can be put in a nutshell of three 
words: competence, solidarity and trust. Then, now and 
forever, they are as essential for a scientist or medical 
practitioner as for any individual’s life. Still more, they 
are pivotal in the fight against crises, including what we 
are now enduring. If we respect and follow them, there 
is no reason to await the future with trepidation. 
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List of neuropathological research visitors and 
postdocs who trained in neuropathology in the NI/KIN: 
 
Masanori Tomonaga, Professor in Tokyo, Riki 
Okeda, Professor in Tokyo, Takeshi Kurata, Professor at 
the NIH Tokyo, Ichiro Akiguchi, Professor in Kyoto, 
Toshihiko Suenaga, Yoshitomo Shirakashi, Yasuhiro Ka-
wamoto, Hiroshi Sugiyama, Toru Kimura, Kyoko Ozawa, 
all Kyoto, Masahiro Yoshimura-Yasuhara, Hitoshi Yama-
nouchi, both Tokyo, Noburo Kochi, Tatsuo Morimura, 
both Hyogo, Kazuko Sato-Matsumura, Sapporo, Sami 
Khoshyomn, Burlington VT, Silvia Cristina, Milano, Gian-
riccardo Trabattoni, Parma, Carlos Lima, Lisboa, Mara 
Popovic, Professor in Ljubljana, Raf Sciot, Louvain, Mar-
cel JHM Herpers, Professor in Maastricht, Ferenc Garzu-
ly, Szombathely, Tibor Hortobágyi, Professor in Szeged, 
Felicia Slowik, Budapest, Andras Guseo, Székesfehérvár, 
Pawel P. Liberski, Professor in Łodz, Beata Sikorska, Pro-
fessor in Łodz, Radek Kordek, Łodz, Maria Barcikowska, 
Łodz, Radek Matej, Professor in Prague, Marin Guent-
chev, Professor in Sofia, Ognan Kalev, Sofia, later Linz, 
Yervand Karapetyan, Armenia, Hussun, Yemen, Sashine 
Tolunay, Bursa, Karl Rössler, Professor in Vienna, Chris-
tian Bancher, Horn, Eduard Auff, Professor in Vienna, 
Stefan Klöppel, Professor in Freiburg i. Br, Peter Pilz, 
Salzburg, Hans Maier, Innsbruck, Christine Wüstinger, 
Johannes Preiser, Elisabeth Wondrusch, Claudia Rad-
bauer, Peter Mazal, Oskar Koperek, Christa Jarius, Elisa-
beth Lindeck-Pozza, Anna C Rudnay, Roland Sedivy, Ute 
Laggner, Irene Pipp, Ivan J Milenkovic, Harald Stefanits, 
all Vienna, Michael Huemer, Schwarzach-St. Veit, Reza 
Yassari, Chicago IL. I apologise to those whom I missed, 
as I could not cross-check the list with documents in the 
institute. 
Past and present neuropathological researchers 
who have worked for prolonged periods in the NI/KIN 
include Ellen Gelpi, Johannes Hainfellner, Christine 
Haberler, Romana Höftberger, Gabor G. Kovacs, Matthi-
as Preusser, Manfred Schmidbauer, Sabine Urbanits, 
Julia Wanschitz, Adelheid Wöhrer. 
 
